Talk to Alison

00 1 718 618 48 97

Search inside this page

All regions

Free Market Research Guides to Download

Blood Supply, Tissue Banking and Transplantation Analysis & Statistics, January 2013 (p4)

You might be interested in: transplantation, blood, cord blood, more »

» Purchase Premium Reports

91-130 of about 200 reports

Estonia Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Estonia

Honduras Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2009
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Honduras

Mexico Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Mexico

Latvia Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Latvia

Israel Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Israel

Greece Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Greece

Chile Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Chile

Bulgaria Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Bulgaria

Hungary Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Hungary

Costa Rica Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Costa Rica
CordLife Pte. Ltd. (CBB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CordLife Pte. Ltd. (CBB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • June 2012
  • by Global Data

CordLife Pte. Ltd. (CBB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary CordLife Pte. Ltd. (Cordlife) is a publicly held healthcare company engaged in collection, processing and storing ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
China Blood Products Industry Report, 2011-2012

China Blood Products Industry Report, 2011-2012

  • $ 2 300
  • Industry report
  • June 2012
  • by Research In China

Blood plasma serves as key raw material in blood product industry. In August 2011, the shut-down of 16 plasma collection stations in Guizhou province, China resulted in a YoY decline of 15% in plasma volume ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : China
Cellavision AB (NA) - Financial and Strategic SWOT Analysis Review

Cellavision AB (NA) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2012
  • by Global Data

Cellavision AB (NA) - Financial and Strategic SWOT Analysis Review Summary CellaVision AB (Cellavision) is a publicly held health care company. It is engaged in development and marketing of system solutions ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Orthopedic: BioMimetic Therapeutics, Inc. (BMTI)

Orthopedic: BioMimetic Therapeutics, Inc. (BMTI)

  • $ 750
  • Company report
  • April 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
Drug Discovery and Development: CryoLife, Inc. (CRY)

Drug Discovery and Development: CryoLife, Inc. (CRY)

  • $ 750
  • Company report
  • April 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the CryoLife, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders

Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders

  • $ 500
  • Industry report
  • April 2012
  • by Global Data

Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders Summary GlobalData's report, ?Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders? takes a look ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Straumann Holding AG (STMN) - Product Pipeline Analysis

Straumann Holding AG (STMN) - Product Pipeline Analysis

  • $ 750
  • Company report
  • April 2012
  • by Global Data

Straumann Holding AG (STMN) - Product Pipeline Analysis Summary Straumann Holding AG (Straumann) is a leading implant, restorative and regenerative dentistry. researches, develops and manufactures dental ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
Disease and Therapy Review:  Kidney Transplant

Disease and Therapy Review: Kidney Transplant

  • $ 995
  • Industry report
  • April 2012
  • by Timely Data Resources Inc.

The Kidney Transplant Disease and Therapy Review provides procedure rates and prevalence numbers and percentages for major countries worldwide. Disease processes which can seriously damage kidneys are ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World
Xeno Transplants Corporation (Symbol:XENO) SWOT Analysis, Strategy, Revenues and Profits

Xeno Transplants Corporation (Symbol:XENO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Clearant, Inc. (Symbol:CLRA) SWOT Analysis, Strategy, Revenues and Profits

Clearant, Inc. (Symbol:CLRA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Tissera, Inc. (Symbol:TSSR) SWOT Analysis, Strategy, Revenues and Profits

Tissera, Inc. (Symbol:TSSR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Israel
CordLife Pte. Ltd. (Symbol:CBB) SWOT Analysis, Strategy, Revenues and Profits

CordLife Pte. Ltd. (Symbol:CBB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Australia, Philippines, Singapore, Indonesia
HTL-STREFA S.A. (Symbol:HTL) SWOT Analysis, Strategy, Revenues and Profits

HTL-STREFA S.A. (Symbol:HTL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Drug Discovery and Development: W. L. Gore & Associates, Inc.

Drug Discovery and Development: W. L. Gore & Associates, Inc.

  • $ 750
  • Company report
  • March 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the W. L. Gore & Associates, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : Australia
Merger & Acquisition in Medical Equipment Industry: Musculoskeletal Transplant Foundation

Merger & Acquisition in Medical Equipment Industry: Musculoskeletal Transplant Foundation

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World, United States
CaridianBCT, Inc. SWOT Analysis, Strategy, Revenues and Profits

CaridianBCT, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • February 2012
  • by Global Data

CaridianBCT, Inc. (CaridianBCT) is a privately held US-based pharmaceutical company. It engages in the development of products in the field of blood banking, therapeutic apheresis and transfusion medicine ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Global Organ and Tissue Transplantation Industry

Global Organ and Tissue Transplantation Industry

  • $ 4 950
  • Industry report
  • February 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Organ and Tissue Transplantation by Number of Procedures. The global and other markets (except the US) are analyzed only by Organ Type - Heart, Kidneys, Liver, ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World, United States
U.S. Market for Wound and Tissue Management 2012 - Executive Summary

U.S. Market for Wound and Tissue Management 2012 - Executive Summary

  • $ 195
  • Industry report
  • February 2012
  • by iData Research, Inc.

The U.S. wound and tissue management market is expected to grow at a CAGR of 5.3% by 2018. The U.S. wound and tissue management market includes: - Wound closure devices, - Static and dynamic compression ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods

Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods

  • $ 3 500
  • Industry report
  • January 2012
  • by GBI Research

Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods Summary GBI Research, the leading business intelligence ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

  • $ 3 995
  • Industry report
  • January 2012
  • by Kalorama Information

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World
West Pharmaceutical Services, Inc.: Company Profile and SWOT Analysis

West Pharmaceutical Services, Inc.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • December 2011
  • by ICD Research

Synopsis ICD Research's "West Pharmaceutical Services, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Global Regenerative Medicine Market

Global Regenerative Medicine Market

  • $ 1 200
  • Industry report
  • December 2011
  • by RNCOS

Regenerative medicine is an emerging interdisciplinary field that spans tissue engineering, stem-cell biology, nanoscience, and bioengineering for the repair of cells, tissues and organs. It seeks to treat ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World
Drug Discovery and Development: AGA Medical Holdings, Inc. (AGAM)

Drug Discovery and Development: AGA Medical Holdings, Inc. (AGAM)

  • $ 750
  • Company report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the AGA Medical Holdings, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
US Bone Grafts Industry

US Bone Grafts Industry

  • $ 4 500
  • Industry report
  • October 2011
  • by Global Industry Analyst

This report analyzes the US market for Bone Grafts in Millions of US$ by the following Product Segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Cytomedix, Inc. (CMXI) - Product Pipeline Analysis

Cytomedix, Inc. (CMXI) - Product Pipeline Analysis

  • $ 750
  • Company report
  • September 2011
  • by Global Data

Cytomedix, Inc. (CMXI) - Product Pipeline Analysis Summary Cytomedix, Inc. (Cytomedix) is a biotechnology company, principally focused on the development of advanced tissue regeneration technologies. Its ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
US Therapeutic Apheresis Industry

US Therapeutic Apheresis Industry

  • $ 4 500
  • Industry report
  • September 2011
  • by Global Industry Analyst

This report analyzes the US market for Therapeutic Apheresis in US$ Thousand by the following procedures: Photopheresis, Plasmapheresis, Erythrocytapheresis, Plateletpheresis, Leukapheresis, and Lipidpheresis. ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Cord Blood America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cord Blood America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2011
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
World Blood Supply, Tissue Banking and Transplantation: Lung Transplantation - Pipeline Review, Q3 2011

World Blood Supply, Tissue Banking and Transplantation: Lung Transplantation - Pipeline Review, Q3 2011

  • $ 500
  • Company report
  • July 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Lung Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World
World Cord Blood Banking Industry Overview

World Cord Blood Banking Industry Overview

  • $ 700
  • Industry report
  • July 2011
  • by Koncept Analytics

Umbilical cord carries rich nutrient blood and gases to the fetus through arteries and veins it encloses. Blood contained in the umbilical cord is rich in stem cells. In the adult body, there are few active ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : China
Human Albumin and Factor Vlll (FVIII) Industry Overview s

Human Albumin and Factor Vlll (FVIII) Industry Overview s

  • $ 800
  • Industry report
  • April 2011
  • by Koncept Analytics

The global blood plasma-derived products industry has shown consistent growth over the period from 2002 to 2009 and the rapid increase in cases of Hemophilia, low treatment cost to patients and rising ...

  • Industries : Blood Supply, Tissue Banking and Transplantation
  • Countries : World, China, United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.